With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

In a commentary accompanying the study, Thomas Yau, MBBS, of the University of Hong Kong, and colleagues noted that anti-CTLA-4-based dual immune checkpoint inhibitor regimens have "revolutionized ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual ...

Morgan Stanley downgraded Adagene (ADAG) to Equal Weight from Overweight with no price target While the firm believes anti-CTLA-4 approaches ...

Short-course radiotherapy (SCRT) followed by fruquintinib plus adebrelimab and CAPOX in the total neoadjuvant therapy of locally advanced rectal cancer (LARC): A multicenter, single-arm, open-label, ...